These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 33244618)
1. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer. Tan H; Sui X; Yin H; Yu H; Gu Y; Chen S; Hu P; Mao W; Shi H Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1966-1975. PubMed ID: 33244618 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
3. Feasibility of ultra-low-activity 18F-FDG PET/CT imaging in children. Wu H; Liu G; Yu H; Zheng Z; He Y; Shi H Br J Radiol; 2025 Jan; 98(1165):136-142. PubMed ID: 39423099 [TBL] [Abstract][Full Text] [Related]
4. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689 [TBL] [Abstract][Full Text] [Related]
5. Multi-level tuberculosis of the spine identified by 18 F-FDG-PET/CT and concomitant urogenital tuberculosis: a case report from the spinal TB X cohort. Scherer J; Mukasa SL; Wolmarans K; Guler R; Kotze T; Song T; Dunn R; Laubscher M; Pape HC; Held M; Thienemann F Infection; 2024 Dec; 52(6):2507-2519. PubMed ID: 38896371 [TBL] [Abstract][Full Text] [Related]
6. Detection of cancer-associated cachexia in lung cancer patients using whole-body [ Ferrara D; Abenavoli EM; Beyer T; Gruenert S; Hacker M; Hesse S; Hofmann L; Pusitz S; Rullmann M; Sabri O; Sciagrà R; Sundar LKS; Tönjes A; Wirtz H; Yu J; Frille A J Cachexia Sarcopenia Muscle; 2024 Dec; 15(6):2375-2386. PubMed ID: 39189415 [TBL] [Abstract][Full Text] [Related]
8. The impact of qualitative [18F]FDG PET/CT in predicting clinical outcomes of post-surgical differentiated thyroid cancer patients with elevated thyroglobulin and negative radioiodine whole-body scan. Ha LN; Phuong NT; Son MH BMC Surg; 2024 Nov; 24(1):377. PubMed ID: 39593022 [TBL] [Abstract][Full Text] [Related]
10. The Effect and Influence of the Responsibility System Rehabilitation Nursing Model in the Nursing of Patients with Ischemic Stroke. Shi W; Liu F; Yuan M; Liu H Altern Ther Health Med; 2024 Dec; 30(12):309-317. PubMed ID: 38581316 [TBL] [Abstract][Full Text] [Related]
11. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE. Robertson L; Broderick C; Yeoh SE; Stansby G Cochrane Database Syst Rev; 2021 Oct; 10(10):CD010837. PubMed ID: 34597414 [TBL] [Abstract][Full Text] [Related]
12. Assessment of dual time point protocols to produce parametric K Reshtebar N; Hosseini SA; Zhuang M; Rahmim A; Karakatsanis NA; Sheikhzadeh P Med Phys; 2024 Dec; 51(12):9088-9102. PubMed ID: 39341228 [TBL] [Abstract][Full Text] [Related]
13. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE. Robertson L; Yeoh SE; Broderick C; Stansby G; Agarwal R Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010837. PubMed ID: 30407621 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the safety, biodistribution, dosimetry of [ Yang L; Guo W; Ding H; Gao X; Xu Y; Wang M; Yang X; Zhao Y; Wang W; Liu W; Jia F; Hou D; Nanding A; Cheng L; Meng H; Wang K Eur J Nucl Med Mol Imaging; 2024 Dec; ():. PubMed ID: 39676103 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic Potential of Supplemental Static and Dynamic Röhrich M; Daum J; Gutjahr E; Spektor AM; Glatting FM; Sahin YA; Buchholz HG; Hoppner J; Schroeter C; Mavriopoulou E; Schlamp K; Grott M; Eichhorn F; Heußel CP; Kauczor HU; Kreuter M; Giesel F; Schreckenberger M; Winter H; Haberkorn U J Nucl Med; 2024 Jun; 65(6):872-879. PubMed ID: 38604763 [TBL] [Abstract][Full Text] [Related]
17. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421 [TBL] [Abstract][Full Text] [Related]
18. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
19. Is there a comparable Mp-MRI for incidental prostate uptake on 18 F-FDG PET/CT? Şam Özdemir M; Kaya N; Savun M; Keskin ET; Yüzkan S; Arslan FZ; Budak B; Omak Ö; Yardımcı AH; Özdemir H World J Surg Oncol; 2024 Dec; 22(1):339. PubMed ID: 39707383 [TBL] [Abstract][Full Text] [Related]
20. Pre-procedure Jin AF; Luo ZH; Qi WL; Liu Q Diagn Interv Radiol; 2024 Nov; 30(6):380-384. PubMed ID: 38293844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]